Health 4 Brands launched in the UK
September 11, 2009Medical Communications Euro RSCG, advertising
Euro RSCG Life has launched Health 4 Brands as a second health agency in the UK. Health 4 Brands (H4B) …
Contract manufacturing news in brief
September 11, 2009Manufacturing and Production
Newsflow in the contract manufacturing sector is picking up again as the summer draws to a close, with new agreements …
Biotech suffers as recession hits
September 11, 2009Medical Communications biotech, intercytex
The fears of many biotech leaders are being realised, as a string of small-scale companies face liquidation at the hands …
Roche divests protein expression portfolio
September 10, 2009Research and Development Roche, genomics
Roche has sold its cell-free protein expression kits business for an undisclosed sum.Berlin-based company RiNA will take control of the …
Cipla plans push into biosimilars
September 10, 2009Sales and Marketing biosimilars, generics
Mumbai-based generics manufacturer Cipla is to begin making biosimilars, generic substitutable versions of branded biologic drugs. It plans to do …
Industry cautions over probe into use of NICE approved drugs
September 10, 2009Sales and Marketing NICE, hc
The UK pharma industry has urged caution over data collected on the use of NICE-approved drugs on the NHS that …
Careers Voice: Making training work
September 10, 2009Business Services careers, careers voice, training
A senior manager in a major pharmaceutical company told me that the industry spends millions on training and next to …
Expanding clinical trials in India: answering the need for training
September 8, 2009Research and Development India, clinical trials
India is widely seen as the most exciting country in the clinical research world. Its potential to deliver large numbers …
Herceptin scientist wins Janssen award for biomedical research
September 8, 2009Research and Development Herceptin, Janssen
Johnson & Johnson has honoured the career achievements of Axel Ullrich by awarding him with the 2009 Dr Paul Janssen …
Observational studies will help answer growing safety demands
September 8, 2009Research and Development ICON, drug safety
The pharmaceutical industry is ready to adapt to growing drug safety requirements, but understanding of how it can capture safety …
OnMedica merges with MedSci
September 7, 2009Medical Communications, Sales and Marketing OnMedica, digi
Online PR company and medical education provider OnMedica Group has merged with medical communications company MedSci.The combined says it will …
Patients on Enbrel work longer, says study
September 7, 2009Research and Development, Sales and Marketing Enbrel, RA
Rheumatoid arthritis patients taking Enbrel are able to keep working for longer, according to a new study comparing its affects …
Blow for Irish pharma sector as Teva, Elan cut staff
September 7, 2009Manufacturing and Production Elan, Teva, lilly
Ireland’s pharmaceutical sector suffered a double blow last week as two drugmakers opted to make staff redundant at manufacturing plants …
NICE backs limited use of Lilly’s Plavix rival
September 7, 2009Research and Development Efient, NICE
NICE has recommended Lilly and Daiichi’s Efient for use on the NHS, giving the blood-thinner drug a boost in its …
Roche and PTC sign CNS research deal
September 4, 2009Research and Development CNS, Roche
PTC Therapeutics has signed an early-stage drug discovery deal with Roche that will focus on treatments for central nervous system …
Cameron: Tories are ‘the party of the NHS’
September 4, 2009NHS, US
David Cameron has called the Conservatives the "party of the NHS," in an attempt to reassure voters the service is …
Head-to-head boost for Brilinta over Plavix
September 4, 2009Research and Development, Sales and Marketing AZ, Brillinta
AstraZeneca has released details of its brand Brilinta’s performance in head-to-head trials with Plavix, the world’s second biggest-selling drug.Earlier this …
Roche’s MabThera expands licence in leukaemia
September 4, 2009Research and Development, Sales and Marketing MabThera, Roche
MabThera has been approved in Europe for use in previously treated chronic lymphocytic leukaemia, which Roche says will offer new …
Latest content
Major funding opportunity opens for early cancer diagnostics
Androlabs receives UK authorisation for new Testavan presentation
CEPI backs African-led Bundibugyo Ebola vaccine development
Cytomos appoints life sciences executive to board
